Generer rapport
Agilent Technologies Denmark Aps
Produktionsvej 42, 2600 Glostrup, CVR 21852902
Virksomhedsform
Anpartsselskab
Etableret
1999
Størrelse
Store
Ansatte
719
Omsætning
1.026
MDKK
Bruttofortj.
175
MDKK
Primært resultat (EBIT)
82
MDKK
Årets resultat
61
MDKK
Egenkapital
654
MDKK
Reklamebeskyttet virksomhed
Denne virksomhed er reklamebeskyttet. Det betyder bl.a. at oplysningerne ikke må bruges til reklamehenvendelser. annonce
Flere nøgletal og analyser?
Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!
Rang Årets resultat
Rang i branche
14/1.796
"Top 10%"
Rang i Danmark
2.487/350.505
"Top 10%"
Direktion top 3
Anders Meier 2 | CEO |
Bestyrelse top 3
Anders Meier 2 | Bestyrelsesformand |
Ieva Blekte Tackie 2 | Bestyrelsesmedlem |
Lene Klejs Stuhr 2 | Bestyrelsesmedlem |
Legale ejere top 3
90-99.99% | Agilent Technologies Luxco LLC | US |
Tegningsregler
Selskabet tegnes af en direktør eller af et bestyrelsesmedlem eller af den samlede bestyrelse
Stamoplysninger baseret på CVR
Navn | Agilent Technologies Denmark Aps |
Binavne | Prozyme Europe Aps, Seahorse Bioscience Europe Aps Vis mere |
CVR | 21852902 |
Adresse | Produktionsvej 42, 2600 Glostrup |
Branche | Engroshandel med andre maskiner og andet udstyr [466400] |
Etableret | 01-07-1999 (25 år) |
Første regnskabsperiode | 01-07-1999 til 31-10-2000 |
Virksomhedsform | Anpartsselskab |
Antal ansatte | 720 (årsværk:712) |
Reklamebeskyttelse | Ja |
Revisor | Bdo Statsautoriseret Revisionsaktieselskab siden 07-10-2019 |
Regnskabsperiode | 01-11 til 31-10 |
Selskabskapital | 5.000.001 DKK 5.000.000 DKK (29-10-1999 - 31-10-2016) 500.000 DKK (01-07-1999 - 28-10-1999) |
Vedtægter seneste | 05-08-2019 |
Medlem af brancherne
- Engroshandel med andre maskiner og andet udstyr [466400]NACE6 indeholdende 2.359 virk.
- Engroshandel med andre maskiner, andet udstyr og tilbehør [466]NACE3 indeholdende 3.759 virk.
- Engroshandel [46]NACE2 indeholdende 25.273 virk.
- Engroshandel og detailhandel [G]NACE1 indeholdende 65.384 virk.
Formål
Selskabets formål er at drive virksomhed med handel, fabrikation og investering samt anden virksomhed, der står i forbindelse hermed.
Regnskab
2024 | 2023 | 2022 | |
---|---|---|---|
Valuta/enhed | 000' DKK | 000' DKK | 000' DKK |
Omsætning | 1.025.827 +7% | 956.183 -1% | 964.729 -9% |
Bruttofortjeneste | 174.828 +32% | 132.500 -8% | 144.480 +24% |
Årets resultat | 61.380 +196% | 20.718 -36% | 32.466 +20% |
Egenkapital | 654.253 +10% | 592.873 +4% | 572.155 +6% |
Balance | 868.813 +2% | 848.308 +6% | 797.672 -5% |
Ledelsesberetning sammendrag
Beskrivelse af virksomhedens væsentligste aktiviteter
Principal activitiesAgilent Technologies Denmark ApS, hereinafter referred to as “company”, operates as a reseller of products/services covering life sciences, diagnostics and applied chemicals markets. A major part of the products/services range is purchased from group companies within and outside of Denmark. The company is also engaged in the business of rendering contract manufacturing, research & development, product marketing and administrative services to group companies outside of Denmark. There is no significant change in the company’s activities or financial and economic conditions.
Beskrivelse af udviklingen i virksomhedens aktiviteter og økonomiske forhold
Development in activities and financial and economic positionThe management continues to work towards achieving operational efficiencies through process realignment and development. The company together with its group companies continues to pursue new products, markets and opportunities. During FY24, the Agilent group witnessed changes in its executive leadership and the new team announced initiatives to better position Agilent in the continuously evolving market landscape. The past year also brought in new macroeconomic and industry specific challenges to our markets. The company implemented measures including cost effectiveness, customer centricity and process simplifications to achieve sustainable profitable growth.
Omtale af betydningsfulde hændelser, som er indtruffet efter regnskabsårets afslutning
Significant events after the end of the financial yearApart from the abovementioned developments, the Board of Directors and Executive Management are not aware of any event after 31st October 2024 that may have a material impact on the company’s financial position.
Beskrivelse af virksomhedens forventede udvikling
Future expectationsThe management recognizes the challenges of the current economic environment but expects a profitable fiscal ahead. The corporate guidance for worldwide Agilent group earnings is publicly available in our first quarter earnings report released on 26th Feb 2025. It is Agilent’s group policy to release estimates of future earnings at a consolidated worldwide level. With respect to the Denmark based company the revenues are estimated to be in a broad range from DKK 900M to 1,100M based on past business trends. The Agilent group expects that market conditions will continue to be challenging and possibly also be affected by increasing uncertainties in global supply chains and tariff concerns. Consequently, the net profits are broadly estimated to be in the range of DKK 40-60M.
Generalforsamlingsdato: 29-04-2025